6929 logo

OrbusNeich Medical Group Holdings Limited Stock Price

SEHK:6929 Community·HK$3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6929 Share Price Performance

HK$3.76
0.31 (8.99%)
HK$3.76
0.31 (8.99%)
Price HK$3.76

6929 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
4 Rewards

OrbusNeich Medical Group Holdings Limited Key Details

US$180.5m

Revenue

US$58.0m

Cost of Revenue

US$122.4m

Gross Profit

US$80.5m

Other Expenses

US$41.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.051
67.85%
23.22%
0%
View Full Analysis

About 6929

Founded
2001
Employees
1477
CEO
David Chien
WebsiteView website
orbusneich.com

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expandable stent system. Its product portfolio covers various treatment processes in percutaneous coronary intervention and percutaneous transluminal angioplasty procedures. It operates in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.

Recent 6929 News & Updates

Recent updates

No updates